These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 845257)

  • 41. The reactivity of the complement system.
    Hadding U
    Monogr Allergy; 1977; 12():36-45. PubMed ID: 335218
    [No Abstract]   [Full Text] [Related]  

  • 42. Structural homologies of component C5 of human complement with components C3 and C4 by neutron scattering.
    Perkins SJ; Smith KF; Nealis AS; Lachmann PJ; Harrison RA
    Biochemistry; 1990 Feb; 29(5):175-80. PubMed ID: 2322569
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complement activation during surgical procedures.
    Hahn-Pedersen J; Sorensen H; Kehlet H
    Surg Gynecol Obstet; 1978 Jan; 146(1):66-8. PubMed ID: 618494
    [No Abstract]   [Full Text] [Related]  

  • 44. Effects of granulocyte neutral proteases on complement components.
    Johnson U; Ohlsson K; Olsson I
    Scand J Immunol; 1976; 5(4):421-6. PubMed ID: 181839
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Study of B-lymphocytes with receptors to C3 component of complement in patients with glomerulonephritis and systemic lupus erythematosus].
    Gordovskaia NB; Bulanova TD; Traianova TG
    Ter Arkh; 1977; 49(7):45-50. PubMed ID: 331546
    [No Abstract]   [Full Text] [Related]  

  • 46. Partial lipodystrophy and glomerulonephritis without complement activation.
    Mery JP; Kourilsky O; Morel-Maroger L; Adam C
    N Engl J Med; 1978 May; 298(18):1034. PubMed ID: 643001
    [No Abstract]   [Full Text] [Related]  

  • 47. Transfer of C3 nephritic factor from mother to fetus. Is C3 nephritic factor IgG?
    Davis AE; Arnaout MA; Alper CA; Rosen FS
    N Engl J Med; 1977 Jul; 297(3):144-5. PubMed ID: 865586
    [No Abstract]   [Full Text] [Related]  

  • 48. Preservation of C3, C5, and C5a functional activities by a new radiolabeling method; demonstration of C5 products in complement-activated serum.
    Kreutzer DL; Kunkel S; Ward PA; Showell H; McLean RH
    J Immunol; 1979 Nov; 123(5):2278-82. PubMed ID: 489983
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Partial lipodystrophy, C3 nephritic factor and clinically inapparent mesangiocapillary glomerulonephritis.
    Bennett WM; Bardana EJ; Wuepper K; Houghton D; Border WA; Götze O; Schreiber R
    Am J Med; 1977 May; 62(5):757-60. PubMed ID: 860726
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Complement studies in severe viral hepatitis of childhood.
    Dupuy C; Dupuy JM
    Pathol Biol (Paris); 1977 Oct; 25(8):553-8. PubMed ID: 339168
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute local inflammation alters synthesis, distribution, and catabolism of third component of complement (C3) in rabbits.
    Manthei U; Strunk RC; Giclas PC
    J Clin Invest; 1984 Aug; 74(2):424-33. PubMed ID: 6746901
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum complement components in patients with trachoma.
    Sen DK; Sarin GS; Hiranandani M; Baveja UK
    Br J Ophthalmol; 1985 Sep; 69(9):707-10. PubMed ID: 3876110
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum complement pattern in essential mixed cryoglobulinaemia.
    Tarantino A; Anelli A; Costantino A; De Vecchi A; Monti G; Massaro L
    Clin Exp Immunol; 1978 Apr; 32(1):77-85. PubMed ID: 668194
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Complement activation in patients with renal failure as detected through the quantitation of fragments of the complement proteins C3, C5, and factor B.
    Oppermann M; Haubitz M; Quentin E; Götze O
    Klin Wochenschr; 1988 Sep; 66(18):857-64. PubMed ID: 3184764
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Correction of complement system failure in patients with chronic prostatitis].
    Teodorovich OV; Shatokhin MN; Mykolaenko TV; Konoplia AI; Krasnov AV; Mavrin MIu; Meshanin NV
    Urologiia; 2011; (4):29-32. PubMed ID: 22066238
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Complement activation in acute glomerulonephritis in children.
    Levy M; Sich M; Pirotzky E; Habib R
    Ric Clin Lab; 1980; 10(1):87-91. PubMed ID: 7008160
    [No Abstract]   [Full Text] [Related]  

  • 57. Metabolism of third complement component (C3) in nephritis. Involvement of the classic and alternate (properdin) pathways for complement activation.
    Hunsicker LG; Ruddy S; Carpenter CB; Schur PH; Merrill JP; Müller-Eberhard HJ; Austen KF
    N Engl J Med; 1972 Oct; 287(17):835-40. PubMed ID: 4627271
    [No Abstract]   [Full Text] [Related]  

  • 58. Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients.
    Alper CA; Rosen FS
    J Clin Invest; 1967 Dec; 46(12):2021-34. PubMed ID: 6074005
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The activation mechanism of the alternative pathway of the human complement system by the immune precipitate formed with F(ab')2 of rabbit IgG antibody: the generation of C3- and C5-cleaving enzymes on the immune precipitate.
    Fujita T; Takiuchi M; Iida K; Nagaki K; Inai S
    Immunochemistry; 1977 Jan; 14(1):25-30. PubMed ID: 849874
    [No Abstract]   [Full Text] [Related]  

  • 60. The alternative pathway of complement activation in the neonate.
    Feinstein PA; Kaplan SR
    Pediatr Res; 1975 Oct; 9(10):803-6. PubMed ID: 1103071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.